Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Parallel Changes in Harvey-Bradshaw Index, TNFα, and Intestinal Fatty Acid Binding Protein in Response to Infliximab in Crohn's Disease.

Al-Saffar AK, Meijer CH, Gannavarapu VR, Hall G, Li Y, Diaz Tartera HO, Lördal M, Ljung T, Hellström PM, Webb DL.

Gastroenterol Res Pract. 2017;2017:1745918. doi: 10.1155/2017/1745918. Epub 2017 Oct 23.

2.

Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.

Cars T, Wettermark B, Löfberg R, Eriksson I, Sundström J, Lördal M.

J Crohns Colitis. 2016 May;10(5):556-65. doi: 10.1093/ecco-jcc/jjv243. Epub 2016 Jan 5.

3.

Dental caries, prevalence and risk factors in patients with Crohn's disease.

Szymanska S, Lördal M, Rathnayake N, Gustafsson A, Johannsen A.

PLoS One. 2014 Mar 7;9(3):e91059. doi: 10.1371/journal.pone.0091059. eCollection 2014.

4.

Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.

Blom K, Rubin J, Halfvarson J, Törkvist L, Rönnblom A, Sangfelt P, Lördal M, Jönsson UB, Sjöqvist U, Håkansson LD, Venge P, Carlson M.

World J Gastroenterol. 2012 Nov 28;18(44):6409-19; discussion p. 6417-8. doi: 10.3748/wjg.v18.i44.6409.

5.

Nitric oxide pathway-related gene alterations in inflammatory bowel disease.

Gillberg L, Varsanyi M, Sjöström M, Lördal M, Lindholm J, Hellström PM.

Scand J Gastroenterol. 2012 Nov;47(11):1283-97. doi: 10.3109/00365521.2012.706830. Epub 2012 Aug 20.

PMID:
22900953
6.

Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1).

Anedda F, Zucchelli M, Schepis D, Hellquist A, Corrado L, D'Alfonso S, Achour A, McInerney G, Bertorello A, Lördal M, Befrits R, Björk J, Bresso F, Törkvist L, Halfvarson J, Kere J, D'Amato M.

PLoS One. 2011;6(12):e29523. doi: 10.1371/journal.pone.0029523. Epub 2011 Dec 21.

7.

[Guidelines don't cover the therapeutic needs for everyone with inflammatory bowel disease].

Lindgren S, Lördal M, Karlén P.

Lakartidningen. 2010 Feb 10-16;107(6):367. Swedish. No abstract available.

PMID:
20297589
8.

Genome-wide association identifies multiple ulcerative colitis susceptibility loci.

McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, Neale BM, Ong RT, Lagacé C, Li C, Green T, Stevens CR, Beauchamp C, Fleshner PR, Carlson M, D'Amato M, Halfvarson J, Hibberd ML, Lördal M, Padyukov L, Andriulli A, Colombo E, Latiano A, Palmieri O, Bernard EJ, Deslandres C, Hommes DW, de Jong DJ, Stokkers PC, Weersma RK; NIDDK IBD Genetics Consortium, Sharma Y, Silverberg MS, Cho JH, Wu J, Roeder K, Brant SR, Schumm LP, Duerr RH, Dubinsky MC, Glazer NL, Haritunians T, Ippoliti A, Melmed GY, Siscovick DS, Vasiliauskas EA, Targan SR, Annese V, Wijmenga C, Pettersson S, Rotter JI, Xavier RJ, Daly MJ, Rioux JD, Seielstad M.

Nat Genet. 2010 Apr;42(4):332-7. doi: 10.1038/ng.549. Epub 2010 Mar 14. Erratum in: Nat Genet. 2011 Apr;43(4):388.

9.

Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patients.

Törkvist L, Halfvarson J, Ong RT, Lördal M, Sjöqvist U, Bresso F, Björk J, Befrits R, Löfberg R, Blom J, Carlson M, Padyukov L, D'Amato M, Seielstad M, Pettersson S.

Inflamm Bowel Dis. 2010 Jun;16(6):907-9. doi: 10.1002/ibd.21105. No abstract available.

PMID:
19760754
10.

Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men.

Schoultz I, Verma D, Halfvarsson J, Törkvist L, Fredrikson M, Sjöqvist U, Lördal M, Tysk C, Lerm M, Söderkvist P, Söderholm JD.

Am J Gastroenterol. 2009 May;104(5):1180-8. doi: 10.1038/ajg.2009.29. Epub 2009 Mar 24.

PMID:
19319132
11.

Contribution of the IBD5 locus to Crohn's disease in the Swedish population.

Törkvist L, Noble CL, Lördal M, Sjöqvist U, Lindforss U, Nimmo ER, Löfberg R, Russell RK, Satsangi J.

Scand J Gastroenterol. 2007 Feb;42(2):200-6.

PMID:
17340776
12.

Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe.

Van Limbergen J, Russell RK, Nimmo ER, Törkvist L, Lees CW, Drummond HE, Smith L, Anderson NH, Gillett PM, McGrogan P, Hassan K, Weaver LT, Bisset WM, Mahdi G, Arnott ID, Sjöqvist U, Lördal M, Farrington SM, Dunlop MG, Wilson DC, Satsangi J.

Inflamm Bowel Dis. 2007 Jul;13(7):882-9.

PMID:
17285593
13.

Steroids reduce local inflammatory mediator secretion and mucosal permeability in collagenous colitis patients.

Taha Y, Raab Y, Carlson M, Larsson A, Lördal M, Lööf L, Thörn M.

World J Gastroenterol. 2006 Nov 21;12(43):7012-8.

14.

Contribution of CARD15 variants in determining susceptibility to Crohn's disease in Sweden.

Törkvist L, Noble CL, Lördal M, Sjöqvist U, Lindforss U, Nimmo ER, Russell RK, Löfberg R, Satsangi J.

Scand J Gastroenterol. 2006 Jun;41(6):700-5.

PMID:
16716969
15.

Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans.

Schmidt PT, Lördal M, Gazelius B, Hellström PM.

Gut. 2003 Jan;52(1):53-6.

16.

A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine.

Lördal M, Navalesi G, Theodorsson E, Maggi CA, Hellström PM.

Br J Pharmacol. 2001 Sep;134(1):215-23.

17.

The tachykinins neurokinin A and substance P, but not neurokinin B, stimulate contraction of isolated muscle cells from rat small intestine.

Lördal M, Hellström PM.

Acta Physiol Scand. 1999 May;166(1):75-6. No abstract available.

PMID:
10372981
18.
19.

Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans.

Lördal M, Wallén H, Hjemdahl P, Beck O, Hellström PM.

Clin Sci (Lond). 1998 Jun;94(6):663-70.

PMID:
9854466
20.

Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.

Lördal M, Bränström R, Hellström PM.

Br J Pharmacol. 1998 Jan;123(1):63-70.

21.

Neurokinin A increases duodenal mucosal permeability, bicarbonate secretion, and fluid output in the rat.

Hällgren A, Flemström G, Hellström PM, Lördal M, Hellgren S, Nylander O.

Am J Physiol. 1997 Nov;273(5):G1077-86. doi: 10.1152/ajpgi.1997.273.5.G1077.

PMID:
9374705
22.

Tachykinins influence interdigestive rhythm and contractile strength of human small intestine.

Lördal M, Theodorsson E, Hellström PM.

Dig Dis Sci. 1997 Sep;42(9):1940-9.

PMID:
9331159
23.

Tachykinins stimulate lipid peroxidation mediated by free radicals in gastrointestinal tract of rat.

Lördal M, Söder O, Hellström PM.

Dig Dis Sci. 1997 Jul;42(7):1524-9.

PMID:
9246058
24.
25.

Tachykinins increase vascular permeability in the gastrointestinal tract of the rat.

Lördal M, Hällgren A, Nylander O, Hellström PM.

Acta Physiol Scand. 1996 Apr;156(4):489-94.

PMID:
8732255
26.

5-Hydroxytryptamine: initiator of phase 3 of migrating motor complex.

Lördal M, Hellström PM.

Acta Physiol Scand. 1995 Oct;155(2):241-2. No abstract available.

PMID:
8669297
27.

Inhibition of the migrating motor complex by duodenal drainage in man.

Nilsson I, Svenberg T, Hedenborg G, Lördal M, Hellström PM.

Neurogastroenterol Motil. 1995 Mar;7(1):31-7.

PMID:
7627864
28.
29.

Calcitonin gene-related peptide stimulates irregular spiking and transit of contents in the small intestine of the rat.

Lördal M, Johansson C, Hellström PM.

Acta Physiol Scand. 1990 Mar;138(3):429-30. No abstract available.

PMID:
2327270
30.

Cisapride induces clustered spikes and irregular spiking of the small intestine of the rat.

Lördal M, Hellström PM, Johansson C.

Scand J Gastroenterol Suppl. 1988;152:48-53.

PMID:
2908190

Supplemental Content

Loading ...
Support Center